Other Names for this Disease
- Küssmaul-Maier disease
- Periarteritis nodosa
How might polyarteritis nodosa be treated?
Few people with polyarteritis nodosa have mild disease that remains stable with nonaggressive therapy; because of the risk for serious health complications, aggressive therapy is often recommended. Treatment may include prednisone in divided doses. Additional therapy, such as cyclophosphamide, chlorambucil, azathioprine, methotrexate, dapsone, cyclosporine, or plasma exchange, may also be recommended. The goal of therapy is remission (to have no active disease) within 6 months or so. At this point the person may be maintained on cyclophosphamide (or other therapy) for a year, before it is tapered and withdrawn over the course of 3 to 6 months.It is very important that people undergoing treatment for polyarteritis nodosa be monitored closely for toxic effects of the drugs or for signs of worsening disease. This monitoring may involve blood counts, urinalyses, serum chemistries, and the ESR on at least monthly intervals.
- Sergent JS. Polyarteritis and Related Disorders. In: Firestein. Kelley’s Textbook of Rheumatology, 8th ed. Philadelphia PA: WB Saunders Company; 2008;
- Polyarteritis nodosa. MedlinePlus. 2010; http://www.nlm.nih.gov/medlineplus/ency/article/001438.htm. Accessed 1/16/2012.